[Radical robot prostatectomy: oncological outcomes].
OBJECTIVE
To review the current literature on oncologic outcomes following robot-assisted laparoscopic radical prostatectomy.


METHODS
A systematic MEDLINE search was performed to retrieve articles relating to oncologic outcomes with robot-assisted laparoscopic prostatectomy. Two reviewers independently selected studies, assessed their methodological quality and extracted data.


RESULTS
Positive surgical margin rates in RALP are commensurate to contemporary open and standard laparoscopic series. Surgical experience and refinement of technique helped decrease positive margins. Long-term biochemical disease-free survival (PSA <0.1 ng/ml) following RALP is currently unknown, with only 2 series reporting data with > 12 month follow-up.


CONCLUSIONS
RALP is a safe and reproducible treatment modality for organ-confined prostate cancer and provides excellent short-term oncological control. Larger studies with long-term oncologic follow-up are needed to establish the efficacy compared to more traditional surgical approaches.
Rodríguez
Esequiel
E
Clinical Instructor & Robotics Fellow, Department of Urology, Universidad de California (Irvine), Orange, CA, USA.
Skarecky
Douglas W
DW
Ahlering
Thomas E
TE
D006801:Humans; D008297:Male; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery*; D012371:Robotics; D016896:Treatment Outcome